Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
23.76
-0.14 (-0.59%)
At close: Jan 17, 2025, 4:00 PM
23.56
-0.20 (-0.84%)
Pre-market: Jan 21, 2025, 5:16 AM EST
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.57 billion as of January 21, 2025. Its market cap has decreased by -42.20% in one year.
Market Cap
1.57B
Enterprise Value
-1.89B
1-Year Change
-42.20%
Ranking
Category
Stock Price
$23.76
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.57B, a decrease of -15.92%. That is a compound annual growth rate of -1.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 1.57B | -13.60% |
Dec 31, 2024 | 1.81B | -32.28% |
Dec 29, 2023 | 2.68B | -8.14% |
Dec 30, 2022 | 2.91B | -19.35% |
Dec 31, 2021 | 3.61B | -43.56% |
Dec 31, 2020 | 6.40B | -43.18% |
Dec 31, 2019 | 11.27B | 141.07% |
Dec 31, 2018 | 4.67B | 7.74% |
Dec 29, 2017 | 4.34B | 72.91% |
Dec 30, 2016 | 2.51B | 8.12% |
Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 352.70B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |